Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 121
11
Diseases
8
Unique genes
0.378
Avg. similarity score
Ataxia-hypogonadism-choroidal dystrophy syndrome
Most-connected disease (8 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Ataxia-hypogonadism-choroidal dystrophy syndrome
Boucher-neuhauser syndrome
Chorioretinal dystrophy, spinocerebellar ataxia, hypogonadotropic hypogonadism syndrome
Trichomegaly-retina pigmentary degeneration-dwarfism syndrome
Mucolipidosis
retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome
Cerebellar ataxia and hypogonadotropic hypogonadism
Cerebellar ataxia-hypogonadism
PNPLA6-related spastic paraplegia with or without ataxia
Beta-sarcoglycanopathy
GNPTG-mucolipidosis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Ataxia-hypogonadism-choroidal dystrophy syndrome | 8 | 8 | 1 |
| Boucher-neuhauser syndrome | 8 | 8 | 1 |
| Chorioretinal dystrophy, spinocerebellar ataxia, hypogonadotropic hypogonadism syndrome | 8 | 8 | 1 |
| Trichomegaly-retina pigmentary degeneration-dwarfism syndrome | 8 | 8 | 1 |
| Mucolipidosis | 7 | 7 | 7 |
| retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome | 6 | 6 | 1 |
| Cerebellar ataxia and hypogonadotropic hypogonadism | 5 | 5 | 2 |
| Cerebellar ataxia-hypogonadism | 5 | 5 | 2 |
| PNPLA6-related spastic paraplegia with or without ataxia | 5 | 5 | 1 |
| Beta-sarcoglycanopathy | 1 | 1 | 1 |
| GNPTG-mucolipidosis | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PNPLA6 | 9 / 11 | Ataxia-hypogonadism-choroidal dystrophy syndrome, Boucher-neuhauser syndrome, Cerebellar ataxia and hypogonadotropic hypogonadism, Cerebellar ataxia-hypogonadism and 5 more |
| GNPTG | 2 / 11 | GNPTG-mucolipidosis, Mucolipidosis |
| RNF216 | 2 / 11 | Cerebellar ataxia and hypogonadotropic hypogonadism, Cerebellar ataxia-hypogonadism |
| SGCB | 2 / 11 | Beta-sarcoglycanopathy, Mucolipidosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Lysosome | KEGG | 4 / 133 | 45.2× | 9.72e-7 | 4.75e-5 ✓ sig. |
| Glycerophospholipid catabolism | Reactome | 1 / 3 | 500× | 2.00e-3 | 2.28e-2 ✓ sig. |
| Defective NEU1 causes sialidosis | Reactome | 1 / 3 | 500× | 2.00e-3 | 2.28e-2 ✓ sig. |
| Other glycan degradation | KEGG | 1 / 18 | 83.4× | 1.19e-2 | 7.61e-2 |
| Negative regulators of DDX58/IFIH1 signaling | Reactome | 1 / 27 | 55.6× | 1.78e-2 | 9.67e-2 |
| TRP channels | Reactome | 1 / 28 | 53.6× | 1.85e-2 | 9.85e-2 |
| Transferrin endocytosis and recycling | Reactome | 1 / 31 | 48.4× | 2.05e-2 | 1.04e-1 |
| Sialic acid metabolism | Reactome | 1 / 33 | 45.5× | 2.18e-2 | 1.08e-1 |
| Glycosphingolipid metabolism | Reactome | 1 / 46 | 32.6× | 3.02e-2 | 1.29e-1 |
| Sphingolipid metabolism | KEGG | 1 / 54 | 27.8× | 3.54e-2 | 1.42e-1 |
| Viral myocarditis | KEGG | 1 / 70 | 21.4× | 4.57e-2 | 1.63e-1 |
| Arrhythmogenic right ventricular cardiomyopathy | KEGG | 1 / 86 | 17.5× | 5.59e-2 | 1.82e-1 |
| Hypertrophic cardiomyopathy | KEGG | 1 / 99 | 15.2× | 6.41e-2 | 1.95e-1 |
| Glycerophospholipid metabolism | KEGG | 1 / 102 | 14.7× | 6.60e-2 | 1.98e-1 |
| Dilated cardiomyopathy | KEGG | 1 / 105 | 14.3× | 6.79e-2 | 2.01e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| N-glycan processing to lysosome | GO:0016256 | 2 / 2 | 2,336× | 1.60e-7 | 1.80e-5 ✓ sig. |
| carbohydrate phosphorylation | GO:0046835 | 2 / 24 | 195× | 4.41e-5 | 1.64e-3 ✓ sig. |
| lysosome organization | GO:0007040 | 2 / 65 | 71.9× | 3.29e-4 | 7.15e-3 ✓ sig. |
| lipid catabolic process | GO:0016042 | 2 / 119 | 39.3× | 1.10e-3 | 1.60e-2 ✓ sig. |
| calcium ion export | GO:1901660 | 1 / 3 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |
| positive regulation of lysosome organization | GO:1905673 | 1 / 4 | 584× | 1.71e-3 | 2.07e-2 ✓ sig. |
| regulation of interferon-beta production | GO:0032648 | 1 / 4 | 584× | 1.71e-3 | 2.07e-2 ✓ sig. |
| secretion of lysosomal enzymes | GO:0033299 | 1 / 5 | 467× | 2.14e-3 | 2.34e-2 ✓ sig. |
| glucose import in response to insulin stimulus | GO:0044381 | 1 / 6 | 389× | 2.57e-3 | 2.58e-2 ✓ sig. |
| regulation of defense response to virus by host | GO:0050691 | 1 / 8 | 292× | 3.42e-3 | 3.03e-2 ✓ sig. |
| ganglioside catabolic process | GO:0006689 | 1 / 8 | 292× | 3.42e-3 | 3.03e-2 ✓ sig. |
| cellular response to pH | GO:0071467 | 1 / 9 | 260× | 3.85e-3 | 3.22e-2 ✓ sig. |
| vascular associated smooth muscle cell development | GO:0097084 | 1 / 10 | 234× | 4.27e-3 | 3.38e-2 ✓ sig. |
| phagosome maturation | GO:0090382 | 1 / 11 | 212× | 4.70e-3 | 3.56e-2 ✓ sig. |
| iron ion transmembrane transport | GO:0034755 | 1 / 11 | 212× | 4.70e-3 | 3.56e-2 ✓ sig. |